A recent study from Karolinska Institutet reveals that gut microbes can convert nitrate and non-heme iron from vegetables into dinitrosyl iron complexes (DNICs), which may offer heart and metabolic health benefits. This research highlights the significant role of gut bacteria in…
The article highlights the historical separation between the fields of eating disorders and obesity, emphasizing the need for a collaborative approach to improve patient assessmen…
The FDA has granted approval for Mounjaro (tirzepatide) to reduce cardiovascular risk in individuals with type 2 diabetes, marking a significant development in diabetes management…
A recent study from Edith Cowan University suggests that young men who consume more legumes may experience better cardiometabolic health, while young women favor cruciferous veget…
Recent data indicates a potential decline in obesity rates in the United States, marking a significant shift in a longstanding public health issue. This change coincides with the…
A recent study published in Nature Medicine found that early time-restricted eating, where participants consumed food between 9:45 a.m. and 5:30 p.m., resulted in significant redu…
A recent analysis indicates that meal timing may significantly affect mortality risk among U.S. adults aged 40 and older. The study found that eating later in the day is associate…
A recent study published in Cell Reports Medicine suggests that short, intense sprint intervals may be more effective than moderate continuous cycling in enhancing cardiometabolic…
A recent study published in Nature reveals that rare mutations in the FNIP1 gene may help individuals burn fat instead of storing it, potentially lowering their risk of diabetes a…
A recent study from the University of Freiburg revealed that consuming 100 grams of sauerkraut daily for four weeks can lead to a reduction in systolic blood pressure among health…
GlycA, an advanced inflammatory biomarker derived from NMR spectroscopy, captures chronic inflammation and is linked to various health risks, including cardiometabolic disease and…
A recent review of 19 clinical trials involving over 13,000 adults highlights the varying impacts of GLP-1 medications on cardiometabolic health, emphasizing the importance of per…